EPCAM and breast cancer: The semiautomated CellSearch® platform (Janssen Diagnostics, Raritan, NJ, USA) isolates breast cancer CTCs using ferromagnetic beads coated in EpCAM and defines CTCs according to morphological characteristics, positive expression of cytokeratins and absence of the leukocyte marker CD45.